Move your team from Abridge to Suki.
Each person gets a short interview, then a personalized step-by-step guide showing exactly where their saved work, prompts, and projects land in Suki — and the few things that need a manual step, walked through. You send one invite; nobody becomes the help desk, and nothing in Abridge is changed or cancelled. Want to see where you’re paying for both first? Run the free audit.
Both tools passively listen to clinician-patient conversations and generate a structured draft note for clinician review before filing. To move from Abridge to Suki: install Suki Assistant (web app, Chrome extension, or iOS/Android), connect it to your EHR, and configure specialty-specific note templates in Suki's settings. Export any custom note structures or macros from Abridge's note editor and recreate them in Suki's personalization settings. Start ambient recording in Suki by opening a patient encounter and tapping the microphone icon; Suki's speaker diarization will handle multi-speaker sessions as Abridge does. To move from Suki to Abridge: enroll through your health system's Epic Workshop deployment (Abridge Inside) or via the Abridge web/mobile app; in Epic, the Abridge tab appears alongside the note and shows the AI draft with Linked Evidence. Both tools require human review and approval before note filing; no content auto-commits.
- Warning: Abridge is primarily deployed through health-system enterprise contracts with Epic deeply embedded; Suki supports Epic, Oracle Health (Cerner), athenahealth, and MEDITECH natively. If your health system is on a non-Epic EHR, Suki's broader integration list is a practical advantage, while Abridge lacks a published non-Epic native path.
- Warning: Abridge's Linked Evidence feature ties every drafted phrase back to the transcript/audio timestamp for auditability; Suki does not publish an equivalent phrase-level source-tracing mechanism, so compliance workflows that rely on note-to-source traceability need re-evaluation before switching.
- Warning: Both tools position themselves as supporting 100+ or multi-specialty settings, but Abridge emphasizes outpatient, ED, and inpatient; verify that your specific specialty's note structure is supported on the destination platform before migrating production workflows.
Both tools offer bidirectional EHR integration that embeds ambient documentation inside the clinician's existing chart workflow. Moving from Abridge Inside (Epic) to Suki: request Suki's Epic integration through your Epic administrator or Suki's enterprise sales team; Suki installs inside Epic Haiku (mobile) and Hyperspace (desktop) similarly to Abridge, with chart sign-off in Hyperspace. For non-Epic EHRs (Oracle Health/Cerner, athenahealth, MEDITECH), Suki has native bidirectional integrations that Abridge does not publicly list — this widens the addressable install base. Moving from Suki to Abridge: Abridge Inside is delivered via Epic's Workshop co-development program, so deployment requires Epic health-system enrollment; the Abridge tab installs into existing Haiku and Hyperspace sessions and pulls chart context bidirectionally. For EHRs other than Epic, Abridge does not publish a native certified connector, so Abridge's feasibility should be confirmed with your EHR vendor before committing to migration.
- Warning: Abridge's EHR integration is built exclusively as an Epic-native product (Abridge Inside); if your organization uses Oracle Health, athenahealth, or MEDITECH, Suki is the only one of these two tools with a published native integration.
- Warning: Suki lists full Epic order entry as 'coming soon' in its Epic integration; Abridge does not advertise order staging at all, so Epic workflows that depend on voice-driven order entry are not fully available on either platform today.
- Warning: Both require enterprise contracting and IT deployment; neither is a self-install tool available to individual clinicians outside a health-system agreement.
Both tools support modifying or refining the clinical note during or after the encounter using voice or natural-language input. Abridge generates the note in real time during the visit so the clinician can review content as the conversation unfolds; post-draft, the clinician uses Abridge's prompt-editing feature to issue plain-language refinement commands (e.g., 'make the assessment more concise'). Suki combines ambient mode with a dedicated dictation and voice-command layer: the clinician can dictate free-form text into note sections, issue commands to pull chart data, or trigger follow-up note creation by voice. Moving from Abridge to Suki: set up Suki's dictation preferences and command vocabulary in Suki Assistant settings; train clinical staff that Suki uses explicit command triggers (e.g., 'Suki, ...') rather than Abridge's prompt-editing text box — the interaction model differs. Moving from Suki to Abridge: expect that the in-note voice-command layer is replaced by Abridge's prompt-editing UI (a text field for natural-language instructions); direct voice-driven EHR task commands (e.g., 'what is my schedule?') are not a published Abridge feature.
- Warning: Abridge's real-time note generation is a passive in-visit capability (the note forms as the conversation proceeds); Suki's ambient mode produces the note after the encounter ends. Clinicians who rely on reviewing and correcting the note mid-visit will notice a workflow difference — Abridge drafts in real time, Suki finalizes post-encounter.
- Warning: Suki's voice commands extend into EHR navigation (schedule lookup, medication list retrieval); Abridge's prompt-editing is scoped to note refinement and does not drive EHR navigation tasks. Teams that use Suki's EHR command shortcuts will not find equivalents in Abridge.
- Warning: Both solutions require clinician sign-off before any note is filed; neither tool auto-commits edits.
Both tools generate diagnosis and billing codes from documented encounter content within the documentation workflow. Moving from Abridge to Suki: Abridge's revenue-cycle module surfaces ICD-10, HCC, and visit-diagnosis codes linked to the conversation via Linked Evidence; Suki surfaces ICD-10, HCC, CPT, and E/M suggestions within the same Suki Assistant session used for note drafting. After switching, configure Suki's coding preferences in the assistant settings and confirm the code types your revenue-cycle team requires are available. Suki explicitly adds CPT and E/M-level code suggestions, which extends coding coverage beyond what Abridge publishes on its official revenue-cycle page. Moving from Suki to Abridge: enable the Abridge revenue-cycle product through your enterprise agreement; the codes appear in the Abridge tab alongside the note, anchored by Linked Evidence so your compliance team can trace each code to the exact conversation moment.
- Warning: Abridge's code suggestions are traceable to the conversation via Linked Evidence, supporting MEAT-style documentation for HCC audits; Suki does not publish an equivalent per-code source-tracing capability, which may matter for health systems with aggressive HCC-capture audit requirements.
- Warning: Suki explicitly lists CPT and E/M codes alongside ICD-10/HCC; Abridge's official revenue-cycle page names ICD-10, HCC, and visit diagnoses — CPT/E/M coverage is mentioned in secondary coverage but is not confirmed on the product page, so validate before relying on CPT capture.
- Warning: Both tools' coding features are part of enterprise offerings; neither publishes a standalone per-code pricing model, so pricing impact on RCM workflows requires negotiation with each vendor.
Both tools offer multilingual support, though they apply it at different points of the encounter workflow. Abridge captures and transcribes conversations held in non-English languages (28 supported, including the 16 most-spoken U.S. languages) and produces the clinical note in English. Suki generates multilingual patient instructions in up to 80 languages at a fifth-grade reading level as output of the ambient documentation workflow. When moving from Abridge to Suki: verify that the non-English languages your clinical team speaks are among Suki's transcription languages (Suki does not publish a specific ASR language count for conversation capture — confirm with Suki sales). After-visit patient instructions can be generated in the patient's language directly through Suki Assistant settings. When moving from Suki to Abridge: confirm the patient languages your practice serves are in Abridge's published 28-language set; note that Abridge's multilingual capability is for conversation capture, not for generating patient-facing materials — after-visit summary translation would need a separate tool or the PVS export pathway.
- Warning: The capabilities operate at different layers: Abridge's multilingual support is primarily conversation transcription into English notes; Suki's primary published multilingual output is patient instructions in 80 languages, not note body language. Switching directions may leave a gap — e.g., moving from Abridge to Suki means verifying Suki handles non-English conversation capture at the same scope.
- Warning: Abridge explicitly states it is not a substitute for a trained medical interpreter and does not translate medical advice; the same caveat applies to Suki's patient instructions, which are AI-generated and should be reviewed for clinical accuracy.
- Warning: Abridge publishes ASR benchmark accuracy data (e.g., Spanish WER 3.1%); Suki does not publish equivalent multilingual ASR accuracy benchmarks, making direct quality comparison difficult before switching.
Both tools produce summaries that surface patient-relevant information beyond the raw note, though they serve slightly different use cases. Abridge's Patient Visit Summary (PVS) auto-generates a plain-language after-visit summary for the patient in real time during the encounter, available in the PVS tab at notes.abridge.com and copyable into the EMR. Suki's chart Q&A and summaries generate a concise clinical overview of patient history and allow clinicians to ask natural-language questions about the chart. When moving from Abridge to Suki for patient-facing summaries: note that Suki's summaries are clinician-facing (chart overview and Q&A), not a direct patient-facing after-visit document. Patient instructions in multiple languages can be generated through Suki's multilingual-patient-instructions capability as a partial substitute. When moving from Suki to Abridge for chart intelligence: Abridge does not advertise a chart Q&A or free-form clinical question feature; the Contextual Reasoning Engine surfaces prior-encounter context into the drafted note, but interactive chart querying is not a published Abridge feature.
- Warning: Suki's chart summaries and Q&A are clinician-facing tools for pre-charting context; they are not a direct substitute for Abridge's patient-facing after-visit summary. A Suki-to-Abridge migration loses the after-visit summary if your workflow relied on Suki generating patient instructions at end of visit.
- Warning: Abridge's PVS is available as a copy/paste into the EMR but is not auto-filed; the workflow change of no longer having a dedicated PVS tab needs to be communicated to clinical staff when switching to Suki.
- Warning: Suki's chart Q&A relies on bidirectional EHR integration pulling live chart data; if the EHR integration is not yet fully configured at go-live, the clinical summary quality will be limited to data shared during the session.